2019
Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome
BRAT, Kristián, Nela ŠŤASTNÁ, Zdeněk MERTA, Lyle J. OLSON, Bruce D. JOHNSON et. al.Základní údaje
Originální název
Cardiopulmonary exercise testing for identification of patients with hyperventilation syndrome
Autoři
BRAT, Kristián (703 Slovensko, domácí), Nela ŠŤASTNÁ (203 Česká republika, domácí), Zdeněk MERTA (203 Česká republika, domácí), Lyle J. OLSON (840 Spojené státy), Bruce D. JOHNSON (840 Spojené státy) a Ivan ČUNDRLE (203 Česká republika, garant, domácí)
Vydání
Plos one, San Francisco, Public Library of Science, 2019, 1932-6203
Další údaje
Jazyk
angličtina
Typ výsledku
Článek v odborném periodiku
Obor
30203 Respiratory systems
Stát vydavatele
Spojené státy
Utajení
není předmětem státního či obchodního tajemství
Odkazy
Impakt faktor
Impact factor: 2.740
Kód RIV
RIV/00216224:14110/19:00109665
Organizační jednotka
Lékařská fakulta
UT WoS
000465223900061
Klíčová slova anglicky
hyperventilation syndrome
Příznaky
Mezinárodní význam, Recenzováno
Změněno: 16. 5. 2019 13:19, Soňa Böhmová
Anotace
V originále
Introduction Measurement of ventilatory efficiency, defined as minute ventilation per unit carbon dioxide production (V-E/VCO2), by cardiopulmonary exercise testing (CPET) has been proposed as a screen for hyperventilation syndrome (HVS). However, increased V-E/VCO2 may be associated with other disorders which need to be distinguished from HVS. A more specific marker of HVS by CPET would be clinically useful. We hypothesized ventilatory control during exercise is abnormal in patients with HVS. Methods Patients who underwent CPET from years 2015 through 2017 were retrospectively identified and formed the study group. HVS was defined as dyspnea with respiratory alkalosis (pH >7.45) at peak exercise with absence of acute or chronic respiratory, heart or psychiatric disease. Healthy patients were selected as controls. For comparison the Student t-test or Mann-Whitney U test were used. Data are summarized as mean +/- SD or median (IQR); p<0.05 was considered significant. Results Twenty-nine patients with HVS were identified and 29 control subjects were selected. At rest, end-tidal carbon dioxide (PETCO2) was 27 mmHg (25-30) for HVS patients vs. 30 mmHg (28-32); in controls (p = 0.05). At peak exercise PETCO2 was also significantly lower (27 +/- 4 mmHg vs. 35 +/- 4 mmHg; p< 0.01) and V-E/VCO2 higher ((38 (35-43) vs. 31 (27-34); p< 0.01)) in patients with HVS. In contrast to controls, there were minimal changes of PETCO2 (0.50 +/- 5.26 mmHg vs. 6.2 +/- 4.6 mmHg; p< 0.01) and V-E/VCO2 ((0.17 (-4.24-6.02) vs. -6.6 (-11.4-(-2.8)); p< 0.01)) during exercise in patients with HVS. The absence of V-E/VCO2 and PETCO2 change during exercise was specific for HVS (83% and 93%, respectively). Conclusion Absence of V-E/VCO2 and PETCO2 change during exercise may identify patients with HVS.